Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study

Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study Prostate Cancer and Prostatic Diseases advance online publication, April 11 2017. doi:10.1038/pcan.2017.14 Authors: H-J Shih, M-C Kao, P-S Tsai, Y-C Fan & C-J Huang
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research